ArticleReproductive sciences (Thousand Oaks, Calif.)2026
Progesterone Levels on the Day of Frozen-thawed Embryo Transfer in Artificial Cycles with Vaginal Progesterone Do not Predict Clinical Pregnancy: a Prospective Study.
Article in Reproductive sciences (Thousand Oaks, Calif.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Some studies have reported that low serum progesterone (P) levels on the day of frozen-thawed embryo transfer (FET) are associated with lower pregnancy rates following artificial endometrial preparation (AEP) cycles. Other studies, however, have found no consistent association between serum P levels and pregnancy outcomes. This prospective cohort study included 235 patients who underwent FET following AEP cycles with estradiol valerate and vaginal micronized P. All patients received either blastocyst- or cleavage-stage embryos derived from their own oocytes, without preimplantation genetic testing for aneuploidies. Blood samples were collected on the day of FET to measure serum P concentrations. Serum P levels on the day of embryo transfer did not differ significantly between patients who achieved CP and those who did not (12.76 ± 4.1 ng/mL vs. 11.9 ± 5.6 ng/mL; p = 0.3318). The optimal serum P cutoff level associated with higher CP rates was 10.6 ng/mL, with a sensitivity of 72%, a specificity of 44%, and an AUC of 0.58, indicating poor predictive value. However, patients with serum P levels above this cutoff had a significantly higher CP rate than those with lower values (25.9% vs. 14.6%; p = 0.0372). In the multivariate logistic regression model, this difference was not statistically significant (OR = 2; 95% CI: 0.9-5). Routine monitoring of serum P levels on the day of embryo transfer in AEP cycles using vaginal micronized P is not justified, as serum P levels do not effectively predict CP outcomes in cycles using autologous oocytes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.